Consequently, combination therapy currently involves the administration of one cholinergic drug (donepezil, galantamine or rivastigmine) and one glutamatergic drug (memantine). There have been no ...

These are known as symptomatic treatments. They include donepezil (part of a family of medicines called cholinesterase inhibitors) and memantine. These are available on the NHS. This type of ...

The introduction of generic Alzheimer’s and other dementia medications also resulted in a drop in OOP costs. Memantine prices ...

The overall rate of emergency room visits for older adults with Alzheimer's disease was 36.1 visits per 1,000 adults in ...

In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defen ...

Anavex announced new data from their phase 2b/3 Alzheimer's trial, which was presented at the CTAD 2024 conference. Read why ...

Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...

Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their cholesterol during 2023/24, the largest number on record and almost 900,000 more ...

To date, treatment options available to cure AD are limited to one N-methyl-D-aspartate receptor antagonist (Memantine) and ...

There are four dementia-specific medications approved in Australia – donepezil, galantamine, rivastigmine, and memantine. These available drugs offer symptomatic relief and are neither disease ...

such as glutamate regulators (memantine) or an orexin receptor antagonist (suvorexant). These prescriptions can help symptoms affecting memory, attention, reasoning, and sleep-wake cycles by ...